Advertisement
Advertisement
RDY
Dr. Reddy's Laboratories Limited - ADR
12.25
USDSponsored
-0.05
-0.41%
Sep 25, 15:59 UTC -4
Closed
Pre-Market
12.46
+0.21
+1.67%
RDY Earnings Reports
Positive Surprise Ratio
RDY beat 23 of 42 last estimates.
55%
Next Report
Date of Next Report
Oct 22, 2026
Estimate for Q2 27 (Revenue/ EPS)
$83.44B
/$9.65
Implied change from Q1 27 (Revenue/ EPS)
+3.01%
/+81.05%
Implied change from Q2 26 (Revenue/ EPS)
-5.49%
/-40.32%
Dr. Reddy's Laboratories Limited - ADR earnings per share and revenue
On Jul 22, 2026, RDY reported earnings of 5.33 USD per share (EPS) for Q1 27, missing the estimate of 9.03 USD, resulting in a -40.99% surprise. Revenue reached 81.00 billion, compared to an expected 83.23 billion, with a -2.69% difference. The market reacted with a -9.39% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 3 analysts forecast an EPS of 9.65 USD, with revenue projected to reach 83.44 billion USD, implying an increase of 81.05% EPS, and increase of 3.01% in Revenue from the last quarter.
FAQ
What were Dr. Reddy's Laboratories Limited - ADR's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Dr. Reddy's Laboratories Limited - ADR reported EPS of $5.33, missing estimates by -40.99%, and revenue of $81.00B, -2.69% below expectations.
How did the market react to Dr. Reddy's Laboratories Limited - ADR's Q1 2027 earnings?
The stock price moved down -9.39%, changed from $12.56 before the earnings release to $11.38 the day after.
When is Dr. Reddy's Laboratories Limited - ADR expected to report next?
The next earning report is scheduled for Oct 22, 2026.
What are the forecasts for Dr. Reddy's Laboratories Limited - ADR's next earnings report?
Based on 3
analysts, Dr. Reddy's Laboratories Limited - ADR is expected to report EPS of $9.65 and revenue of $83.44B for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.